ŷAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

6th ŷAV / SCI Ion Channels as Therapeutic Targets symposium

24 February 2020 09:00 - 25 February 2020 16:00, Cambridge, United Kingdom


Introduction
Synopsis
Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain. 

This symposium, the 6th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.

Who should attend
Scientists from industry and academia interested in the therapeutic potential of ion channels. The organising committee particularly welcomes attendance and participation of students working in the field of ion channel research.

Features
• Medicinal chemistry case studies of ion channels as therapeutic targets
• Advances in structure determination techniques and successful structure determinations of key ion channels
• Novel pharmacology and target validation
• Emerging technologies for targeting, assaying and modulating ion channel targets
• Plenary speakers, poster sessions, trade exhibition, on-site accommodation and dinner

Posters
Abstracts were invited for posters and the closing date was 15th November.  Posters will be displayed throughout the meeting, and there will be the option to give a two-minute oral “flash” presentation.  There will be a dedicated poster session on Monday evening.

Registration, Students and Bursaries
Registration is open, and fees include the conference dinner at the Wellcome Trust on Monday evening.   Late rates from 23rd January are:
£380  Member of the ŷAV or SCI
£440  Non-member
£200  Student* member of the ŷAV or SCI
£220  Student* non-member
* Student is an undergraduate or postgraduate, not post-doc
Discounted registration fees are available for students, and some student bursaries are available shortly from the ŷAV and SCI.

Exhibitors
There will be a relevant trade exhibition.  Stand space will measure 3 m wide x 2 m deep, and will include a table, chair, electrical and wi-fi access.   The charge for an exhibition stand space with one full delegate is £900 (including the conference dinner).
There is an option for delegate pack inserts, charged at £250.

Conference Dinner
The conference dinner will be held at the Wellcome Trust and is included in the registration fee.

Venue and Travel
Address:  Wellcome Genome Campus Conference Centre, Hinxton, Cambridge  CB10 1RQ, UK.
By air: Stansted airport is 20 minutes’ drive, London City and Luton are 60 minutes, and Heathrow and Gatwick are 90 minutes..

Accommodation
Accommodation is available at the conference venue, to be booked separately.  The charge for an en suite room, single occupancy, is £102 including breakfast.  Bedrooms are available on Sunday and Monday, 23rd and 24th February (limited availability).

Sponsors
Sponsors are encouraged to support this well-respected event, and we are grateful to our confirmed sponsors.
Speakers
  • Keynote: Martin Gosling Enterprise Therapeutics, United Kingdom
  • Radu Aricescu MRC Laboratory of Molecular Biology, United Kingdom
  • David J Beech University of Leeds, United Kingdom
  • Andrea Brüggemann Nanion Technologies, Germany
  • Liz Carpenter Structural Genomics Consortium, University of Oxford, United Kingdom
  • Henry Danahay Enterprise Therapeutics, United Kingdom
  • Phil Kym AbbVie, United States
  • Michael Letavic Janssen Research & Development, United States
  • Ulrich Zachariae School of Life Sciences, University of Dundee, United Kingdom
  • Jonathan Bentley Evotec, United Kingdom
  • Robin Bon University of Leeds, United Kingdom
  • Thomas Müller Bayer, Germany
  • Anders Riisager NMD Pharma, Denmark
  • Lars Knutsen NMD Pharma, Denmark
  • Mathieu Botte leadXpro AG, Switzerland
  • Jonathan Large LifeArc, United Kingdom
  • Marc Rogers Metrion Biosciences, United Kingdom
  • Katherine Norman University of Leeds, United Kingdom
  • Genevieve Evans KU Leuven, Belgium

Sponsorship & supporting organisations
Venue
Wellcome Genome Campus Conference Centre

Auditorium, Wellcome Genome Campus Conference Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom

Useful links

Committee
Organised by
ŷAV BMCS and SCI FCG
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*